-
PublishedSeptember 2, 2021
Portland’s ImmuCell targeted by New York law firm over FDA setback
The law firm issued a solicitation for plaintiffs after some bad news about a product under development caused the company's stock price to drop.
-
PublishedFebruary 22, 2021
ImmuCell reports 2020 sales boost, new product update
The Portland-based animal health company reported a 12% increase in sales and progress on its efforts to earn regulatory approval for a new product called Re-Tain.
-
PublishedNovember 12, 2020
Portland’s ImmuCell boosts sales by 25% in third quarter
The animal health company still reported a net loss for the quarter as product development expenses remained high.
-
PublishedAugust 13, 2020
Portland-based ImmuCell reports increased revenue, net loss for second quarter
The bovine health products maker reported sales of $3 million and a net loss of $766,000 for the quarter ending June 30.
-
PublishedJune 16, 2020
ImmuCell receives $500,000 loan from Maine Technology Institute
The Portland-based animal health company will use the funds to help increase its production capacity for one product and complete the development of another.
-
PublishedMay 13, 2020
Portland-based ImmuCell reports record sales in first quarter
The maker of animal health products says it is trying hard to keep workers on the production line safe from coronavirus.
-
PublishedFebruary 19, 2020
ImmuCell reports 25 percent revenue increase in 2019
The Portland-based animal health company still reported a $1.3 million net loss for the year.
Immucell
advertisement